B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection is a research paper published in PLOS Pathogens (2020). On theSindex it has a DataRank of 0.564. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Foundation for the National Institutes of Health
Grant: CA229673-01A1
NCI NIH HHS
Grant: P30 CA014520
Foundation for the National Institutes of Health
Grant: CA232616-02
Foundation for the National Institutes of Health
Grant: AI147060-01A1
NCI NIH HHS
Grant: R01 CA229673
Foundation for the National Institutes of Health
Grant: CA014520-45
NIAID NIH HHS
Grant: R01 AI147060
Medical Research Council
Grant: MR/S022597/1
Functional investigation of Epstein-Barr virus infection and latent gene function using natural variants found in normal infections and cancer cells
NCI NIH HHS
Grant: P01 CA022443
NCI NIH HHS
Grant: R01 CA232616
Foundation for the National Institutes of Health
Grant: CA009135
Foundation for the National Institutes of Health
Grant: CA022443-42
NCI NIH HHS
Grant: T32 CA009135
National Institutes of Health
Grant: 5R01CA229673-03
Role of EBV Lytic Infection in Viral Tumorigenesis
National Institutes of Health
Grant: 3T32CA009135-13S1
PREDOCTORAL TRAINING IN EXPERIMENTAL ONCOLOGY
National Institutes of Health
Grant: 2P01CA022443-31
Mechanisms of Reactivation of Epstein-Barr Virus from Latency to Lytic Replicatio
National Institutes of Health
Grant: 3P01CA022443-43S1
Developing and Applying a Safe, Tractable Derivative of SARS-CoV-2
National Institutes of Health
Grant: 5R01AI147060-05
Effects of EBV Type on Viral Reactivation
National Institutes of Health
Grant: 1R01CA232616-01
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
National Institutes of Health
Grant: 5P30CA014520-18
CANCER CENTER SUPPORT
National Institutes of Health
Grant: 5R01AI147060-02
Effects of EBV Type on Viral Reactivation
FWCI
1.67
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals